Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons

NCT02403648 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoglycemia

Interventions

DRUG: BIOD-961
DRUG: Lilly Glucagon
DRUG: Novo Glucagon

Sponsor

Biodel